Global Primary Antibodies Market, By Type (Monoclonal Antibodies, Polyclonal Antibodies), Technology (Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Other Technologies), Source (Mouse, Rabbit, Goat, Other Sources), Research Area (Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology, Others), Application (Proteomics, Drug Development, Genomics), End User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Primary Antibodies Market
Primary antibodies market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Analysis analyses the market for growth in the above forecast timeframe at a CAGR of 7.70%. Increasing levels of investment in research and development activities will further create lucrative opportunities for market growth.
Often referred to as immunoglobulin (Ig), antibodies (Ab) are the big, Y-shaped proteins formed primarily in response to pathogens such as viruses and bacteria by plasma cells present in the blood. Antibodies are capable of using harmful agents to recognise specific molecules. Antibodies are used in multiple clinical fields as well as in the diagnosis of signs of diseases such as rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, macular degeneration, asthma, Crohn's disease, and hypercholesterolemia.
Increasing number of stem cell and neurobiology research, rising academic research and industry collaborations, growing availability of the technologically advanced products, increasing focus on the biomarker discovery are some of the major as well as impactful factors which will likely to augment the growth of the primary antibodies market in the projected timeframe of 2021-2028. On the other hand, increasing number of applications from emerging economies along with rising demand for personalized medicines and protein therapeutics which will further contribute by generating immense opportunities that will led to the growth of the primary antibodies market in the above mentioned projected timeframe.
Increasing concern regarding the quality of antibodies along with rising pressure of pricing by prominent vendors which will likely to act as market restraint factor for the growth of the primary antibodies in the above mentioned projected timeframe. Time consuming as well as costly development process which will become the biggest and foremost challenge for the growth of the market.
This primary antibodies market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on primary antibodies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Primary Antibodies Market Scope and Market Size
Primary antibodies market is segmented on the basis of type, technology, source, research area, application, end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, the primary antibodies market is segmented into monoclonal antibodies, and polyclonal antibodies.
- On the basis of technology, the primary antibodies market is segmented into immunohistochemistry, immunofluorescence, western blotting, flow cytometry, immunoprecipitation, ELISA, and other technologies.
- Based on source, primary antibodies market is segmented into mouse, rabbit, goat, and other sources.
- On the basis of research area, the primary antibodies market is segmented into infectious diseases, immunology, oncology, stem cells, neurobiology, and others.
- Based on application, the primary antibodies market is segmented into proteomics, drug development, and genomics.
- Primary antibodies market has also been segmented based on the end user into pharmaceutical and biotechnological companies, academic and research institutes, and contract research organizations.
Primary Antibodies Market Country Level Analysis
Primary antibodies market is analysed and market size insights and trends are provided by country, type, technology, source, research area, application and end user as referenced above.
The countries covered in the primary antibodies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The U.S. dominates the North America primary antibodies market due to the growing number of stem cell, biomedical and cancer research along with increasing occurrences of chronic disorders in the region, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the surging levels of investment on research and development activities in the region.
The country section of the primary antibodies market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Primary antibodies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for primary antibodies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the primary antibodies market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Primary Antibodies Market Share Analysis
Primary antibodies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to primary antibodies market.
The major players covered in the primary antibodies market report are Thermo Fisher Scientific Inc; Abcam plc; Merck KGaA; BD; Cell Signaling Technology, Inc.; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; GenScript; PerkinElmer Inc.; Lonza; BioLegend, Inc.; QIAGEN; Bio SB; Sysmex Corporation; Jackson ImmunoResearch Inc.; OriGene Technologies, Inc.; Bethyl Laboratories, Inc.; Miltenyi Biotec; Affinity Biologicals Inc.; Active Motif, Inc.; Enzo Life Sciences, Inc.; Rockland Immunochemicals, Inc.; HiMedia Laboratories; among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
